Cheng Cai Tang

Pharmacokinetics, Pharmacodynamics, and Proposed Dosing of the Oral JAK1 and JAK2 Inhibitor Baricitinib in Pediatric and Young Adult CANDLE and SAVI Patients

Hanna Kim, Kristina M. Brooks, Cheng Cai Tang et al. · Clinical Pharmacology & Therapeutics · 2017 · 131 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Evaluating the Relationship between Vancomycin Trough Concentration and 24-Hour Area under the Concentration-Time Curve in Neonates

Sheng-Hsuan Tseng, Chuan Poh Lim, Qi Chen et al. · Antimicrobial Agents and Chemotherapy · 2018 · 47 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Pharmacokinetics, safety, and tolerability of single‐ and multiple‐dose exenatide once weekly in <scp>C</scp>hinese patients with type 2 diabetes mellitus (对中国2型糖尿病患者单次和多次给予艾塞那肽周制剂的药代动力学、安全性和耐受性研究)

Yi Cui, Xiao Hui Guo, Dong Mei Zhang et al. · Journal of Diabetes · 2013 · 19 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacology +15

A model‐based simulation of glycaemic control and body weight when switching from semaglutide to 3.0‐ and 4.5‐mg doses of once‐weekly dulaglutide

Lai Tham, Kevin M. Pantalone, Kathleen Dungan et al. · Diabetes Obesity and Metabolism · 2021 · 14 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17